Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Shuttle Pharmaceuticals Holdings Inc SHPH

Healthcare Biotechnology
Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company. The Company is focused on improving the outcomes of cancer patients treated with radiation therapy (RT). It is developing a pipeline of products designed to address cancer therapies as well as to extend to the new applications of radiation therapy. Its product candidates include... see more

Recent & Breaking News (NDAQ:SHPH)

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024

GlobeNewswire April 3, 2024

Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update

PR Newswire March 22, 2024

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024

GlobeNewswire March 5, 2024

Shuttle Pharma Announces Its Intent to Pursue a Rights Offering

PR Newswire February 13, 2024

Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

PR Newswire January 23, 2024

Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

PR Newswire January 8, 2024

Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

PR Newswire December 11, 2023

Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023

PR Newswire November 30, 2023

Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update

PR Newswire November 14, 2023

Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement

PR Newswire October 31, 2023

Shuttle Pharma to Participate in the Lytham Partners Fall 2023 Investor Conference

PR Newswire October 10, 2023

Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

PR Newswire September 25, 2023

Shuttle Pharma Participates in Hampton University Proton Therapy Institute Prostate Cancer & Men's Health Fair

PR Newswire September 13, 2023

Shuttle Pharma Expands Patent Coverage on HDAC Inhibitor Platform

PR Newswire September 11, 2023

Shuttle Pharma's Selective HDAC6 Inhibitor Shown to Stimulate Innate Immune Response in Pre-clinical Studies, as Reported in Molecular Cancer Therapeutics

PR Newswire August 29, 2023

Shuttle Pharmaceuticals Provides Second Quarter 2023 Corporate Update

PR Newswire August 15, 2023

Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial

PR Newswire August 3, 2023

Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Update

PR Newswire May 26, 2023

Shuttle Pharmaceuticals to Participate in the Lytham Partners Spring 2023 Investor Conference

PR Newswire May 17, 2023

Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation Candidates

PR Newswire March 22, 2023